West Pharmaceutical Services, Inc. Share Price Deutsche Boerse AG

Equities

WPS

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 07:03:12 10/06/2024 BST After market 21:00:01
290.4 EUR +1.04% Intraday chart for West Pharmaceutical Services, Inc. 297.2 +2.36%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 3.01B 2.8B 237B Sales 2025 * 3.28B 3.05B 258B Capitalization 22.92B 21.3B 1,801B
Net income 2024 * 573M 532M 45.01B Net income 2025 * 672M 624M 52.79B EV / Sales 2024 * 7.41 x
Net cash position 2024 * 617M 573M 48.45B Net cash position 2025 * 1.02B 943M 79.75B EV / Sales 2025 * 6.68 x
P/E ratio 2024 *
40.8 x
P/E ratio 2025 *
35.5 x
Employees 10,600
Yield 2024 *
0.3%
Yield 2025 *
0.35%
Free-Float 96.38%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy CI
Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing MT
Declaration of Voting Results of the West Pharmaceutical Services Inc CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023. CI
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400 MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29 MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
More news
1 day+3.43%
1 week-4.28%
Current month-3.68%
1 month-13.80%
3 months-10.76%
6 months-7.98%
Current year-8.77%
More quotes
1 week
287.40
Extreme 287.4
299.20
1 month
287.40
Extreme 287.4
335.70
Current year
287.40
Extreme 287.4
380.10
1 year
287.40
Extreme 287.4
380.10
3 years
209.35
Extreme 209.35
420.20
5 years
104.98
Extreme 104.98
420.20
10 years
28.86
Extreme 28.862
420.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 23/04/15
Director of Finance/CFO 55 20/06/18
Chief Tech/Sci/R&D Officer 52 25/02/18
Members of the board TitleAgeSince
Director/Board Member 66 31/01/11
Chief Executive Officer 55 23/04/15
Director/Board Member 63 11/09/16
More insiders
Date Price Change
10/06/24 290.4 +1.04%
07/06/24 287.4 -1.30%
06/06/24 291.2 +0.17%
05/06/24 290.7 -2.84%
04/06/24 299.2 -1.38%

Delayed Quote Deutsche Boerse AG, June 10, 2024 at 07:03 am

More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
314.7 USD
Average target price
397.1 USD
Spread / Average Target
+26.20%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW